Basic Information
VCCT is a growth-stage biotechnology company dedicated to developing a series of ex vivo and in vivo cell therapy solutions for ocular diseases. VCCT is a proud member of the Kobe Eye Center Initiative, an alliance of organizations that unites research, clinical practice, and patient care to benefit patients with ocular diseases. Guided by the principle of "providing comprehensive solutions for every patient," we challenge ourselves to explore every possible avenue to improve the lives of those with visual impairments.